Company: CSTL
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001628280-25-048254
Chunk: 29

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-11-03
Form: 10-Q
Item: Item 1
Chunk 29
---
 a meaningful estimate of the amount or range of loss, if any, that could result from any unfavorable outcome.

22

Table of ContentsCASTLE BIOSCIENCES, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)(UNAUDITED)

13. Stock Incentive Plans and Stock-Based Compensation

Equity Incentive PlanOn July 24, 2019, we adopted the 2019 Equity Incentive Plan (the “2019 Plan”). The 2019 Plan provides for automatic annual increases to the number of shares authorized for issuance, equal to 5% of our common shares outstanding as of the immediately preceding year end, through January 1, 2029. Under this provision, effective January 1, 2025, an additional 1,424,159 shares became available under the 2019 Plan. As of September 30, 2025, 1,082,161 shares remained available for grant under the 2019 Plan. Inducement PlanOn December 22, 2022, our board of directors approved the 2022 Inducement Plan (the “Inducement Plan”). On August 5, 2025, our compensation committee amended the Inducement Plan to increase the number of shares issuable under the Inducement Plan by 700,000 shares. The Inducement Plan provides for the granting of awards as inducement material to the grantee’s entering into employment with us to the extent such grantee was not previously an employee of ours or is entering into employment following a bona fide period of non-employment with us. As of September 30, 2025, there were 828,770 shares available for grant under the amended Inducement Plan.Stock OptionsStock option activity under our stock plans for the nine months ended September 30, 2025 is set forth below:  Weighted-Average  Stock OptionsOutstandingExercisePriceRemainingContractualTerm (Years)AggregateIntrinsicValue(in thousands)Balance as of December 31, 20242,989,763 $36.23 Granted— $— Exercised(20,995)$5.44 Forfeited/Cancelled(88,499)$44.74 Balance as of September 30, 20252,880,269 $36.19 4.8$8,933 Exercisable as of September 30, 20252,